Clinical Trial
doi: 10.1016/s0041-1345(00)02308-3.
Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation
Affiliations
- PMID: 11267168
- DOI: 10.1016/s0041-1345(00)02308-3
Item in Clipboard
Clinical Trial
Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation
Transplant Proc.
2001 Feb-Mar.
No abstract available
Similar articles
-
Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.Int Immunopharmacol. 2006 Dec 20;6(13-14):1984-92. doi: 10.1016/j.intimp.2006.07.018. Epub 2006 Aug 10. Int Immunopharmacol. 2006. PMID: 17161352 Clinical Trial.
-
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.Transplantation. 2008 Nov 15;86(9):1241-8. doi: 10.1097/TP.0b013e318188af15. Transplantation. 2008. PMID: 19005406 Clinical Trial.
-
Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.Transplant Proc. 2005 Mar;37(2):791-4. doi: 10.1016/j.transproceed.2004.12.185. Transplant Proc. 2005. PMID: 15848533 Clinical Trial.
-
The role of newer monoclonal antibodies in renal transplantation.Transplant Proc. 2001 Feb-Mar;33(1-2):1000-1. doi: 10.1016/s0041-1345(00)02303-4. Transplant Proc. 2001. PMID: 11267163 Review. No abstract available.
-
Mycophenolate mofetil, tacrolimus, Neoral: from clinical trials to the clinic.Transplant Proc. 1998 Aug;30(5):2223-5. doi: 10.1016/s0041-1345(98)00597-1. Transplant Proc. 1998. PMID: 9723448 Review. No abstract available.
Cited by
-
Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation.Biologics. 2009;3:319-36. doi: 10.2147/btt.2009.3257. Epub 2009 Jul 13. Biologics. 2009. PMID: 19707418 Free PMC article.
-
Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.Ann Surg. 2004 Sep;240(3):510-6; discussion 516-7. doi: 10.1097/01.sla.0000137140.79206.d0. Ann Surg. 2004. PMID: 15319722 Free PMC article.
-
Steroid avoidance or withdrawal for kidney transplant recipients.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD005632. doi: 10.1002/14651858.CD005632.pub3. Cochrane Database Syst Rev. 2016. PMID: 27546100 Free PMC article.
-
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006. Drugs. 2001. PMID: 11708766 Review.
-
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.Clin J Am Soc Nephrol. 2008 Mar;3 Suppl 2(Suppl 2):S101-16. doi: 10.2215/CJN.03510807. Clin J Am Soc Nephrol. 2008. PMID: 18308998 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
